DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Acutaas Chemicals Limited — Key licenses/regulatory approvals (Sub-para 12-Para B)

NSE 1 hr ago·18 Aug 2026, 6:06 am

Acutaas Chemicals

Acutaas Chemicals Limited has informed the stock exchanges that it has obtained key licenses and regulatory approvals as required under a specific clause of its terms. This development is a significant administrative milestone for the company.

For investors, this clearance is a positive step as it removes a major regulatory hurdle. It indicates that the company is in full compliance with the necessary legal frameworks, which is essential for its operations and future growth.

Investors should now monitor the company's upcoming announcements for details on how these approvals will impact its operational capacity and business strategy.